Position in FLGT
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,892,559
-$613,802 QoQ
Shares Held
181,922
+36.3% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $605,799,032 across 20 Diagnostics & Research names. FLGT ranks #20 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
418,106 | $205,511,640 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
207,403 | $116,537,670 | |
| 3 | LH |
Labcorp Holdings Inc.
|
214,847 | $57,323,327 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
293,532 | $50,058,945 | |
| 5 | A |
Agilent Technologies, Inc.
|
358,177 | $40,825,013 | |
| 6 | CSTL |
Castle Biosciences Inc
|
811,324 | $19,918,003 | |
| 7 | DHR |
Danaher Corp /De/
|
99,515 | $18,868,043 | |
| 8 | QGEN |
Qiagen N.V.
|
427,030 | $17,098,280 |
All Filings in FLGT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,892,559 | 181,922 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,506,361 | 133,474 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,053,639 | 90,869 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $822,713 | 41,384 | Shares | Defined | 2025-07-28 | |
| 2021-09-30 | $286,670 | 3,187 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $681,948 | 7,394 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $912,092 | 9,440 | Shares | Defined | 2021-05-13 | |
| 2020-03-31 | $274,864 | 25,545 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||